Literature DB >> 622225

Effect of pregnancy on liver tumor associated with oral contraceptives.

D R Kent, E D Nissen, S E Nissen, D J Ziehm.   

Abstract

Four cases of liver adenoma associated with oral contraceptives complicating pregnancy are reported. All patients were symptomatic during pregnancy and 2 were admitted with rupture of the adenoma. One subsequently died. Increased growth and vascularity of adenomas during pregnancy is highly likely. The potential for development of lethal complications is considerable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 622225

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

2.  Spontaneous haemoperitoneum from rupture of a primary hepatic adenoma in an adult man.

Authors:  P D McInerney; M G van Dessel; D A Berstock
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

Review 3.  Management of hepatic adenomatosis.

Authors:  Manish Thapar; Oleg Grapp; Constantine Fisher
Journal:  Curr Gastroenterol Rep       Date:  2015-03

Review 4.  Pregnancy and liver disease.

Authors:  M M Steven
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

5.  Subcapsular hematoma of the liver and pylethrombosis in the setting of cholestatic liver injury.

Authors:  H Sakamoto; M Suga; I Ozeki; T Kobayashi; T Sugaya; Y Sasaki; N Azuma; F Itoh; S Sakamoto; A Yachi; K Imai
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

6.  Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study.

Authors:  Annalisa Sechi; Laura Deroma; Annunziata Lapolla; Sabrina Paci; Daniela Melis; Alberto Burlina; Francesca Carubbi; Miriam Rigoldi; Maja Di Rocco
Journal:  J Inherit Metab Dis       Date:  2012-05-05       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.